Sorry, this entry is only available in Ukrainian.
У МОЗ ініціюють оптимізацію механізму державної реєстрації лікарських засобів
Вас может заинтересовать:
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
WEB only
PJSC “FITOFARM” continues to resume production of its drugs. The company concluded an agreement on contract production with a new partner – PE “KILAFF”. The “KILAFF” company is a reliable…
